Login
Toggle navigation
Videos
Categories
Trending
Friále invest in start-ups all over the world|Bryan Frist,Managing Partner,Friale
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Bryan Frist is the Founder & Managing Partner of Friále.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Top 5 Criteria for Choosing a Record Keeper
00:10:00
Jayne Hrdlicka on A2 Milk’s Unique Protein Benefits and Expansion into U.S. and China Markets | Jayne Hrdlicka, CEO , A2 Milk Company.
00:10:00
Mod Resources: Exciting Copper Discovery and Pre-Feasibility Progress
00:10:00
Josh Sapan on the Future of Entertainment: Insights from the Breakaway CEO Summit | Josh Sapan, CEO, AMC Networks Inc.
00:10:00
DFSLab who launched a Blockchain Bootcamp for African startups with Stellar|Stephen Deng,Co-Founder and Partner,DFS Lab
00:10:00
Siriphong Aunthornphan and AIT's move into the AEC market|CEO , Advanced Information Technology Public Company Limited
00:10:00
Nouveau Monde Graphite: Strategic Advances, Management Updates, and Future Catalysts
00:10:00
From $0 to $30k: Teaching Spanish and Overcoming Money Stigma | Nate Hoskin - Founder & Lead Advisor of Hoskin Capital
00:10:00
Barbados Invites Diaspora to Virtual Financial Opportunities Webinar
00:10:00
focus on digital health and enterprise with a little bit of automation and writing initial checks typically more on their investment thesis|Amit Garg,Managing Partner,Tau Ventures
00:10:00
George Chryssides discusses his interest in new religious movements and Jehovah's Witnesses.|George Chryssides,Professor,York St John University
00:10:00
From U.S. REITs to Global Real Assets Leadership | Bob Steers, Executive Chairman , Cohen & Steers Inc.